# Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.

> **NCT06146062** · PHASE2 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 68 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Mesenchymal Stromal Cells (MSC)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06146062
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146062, "Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06146062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*